A Tale from the Dusty Corner: Health Catalyst Inc (HCAT) Stock

Evercore ISI raised the price target for the Health Catalyst Inc (NASDAQ:HCAT) stock from “an In-line” to “an Outperform”. The rating was released on January 03, 2024, according to finviz. The research report from JP Morgan has upgraded the stock from Neutral to Overweight, with a price target set at $11. The stock was upgraded by Piper Sandler, who disclosed in a research note on November 13, 2023, from Neutral to Overweight and set the price objective to $11. In their research brief published August 01, 2023, Cantor Fitzgerald analysts initiated the Health Catalyst Inc stock to Overweight with a price target of $16.

Historical Earnings Surprises and Revenue Forecasts

It appears that the average earnings per share estimate for the current quarter (ending in Mar 2024) is $0.03. This is an average of 14 analysts’ earnings, where the high earnings per share estimate is $0.06 and the low earnings per share estimate is -$0.06. According to 16 analyst estimates, an average revenue estimate of $75.08M is projected for the current quarter with a high revenue estimate of $79.6M and a low estimate of $74.05M.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

The latest trade, Performances and Moving Averages give us the following Picture

The firm’s stock price fluctuated -7.15% within the last five trades and -7.72% within the last 30 trades, which was a significant change from the beginning of this year. Despite the fact that the share price decreased -19.47% in the last 6 months and -21.32% was subtracted to its value over the previous 3 months. HCAT stock is trading at a margin of -7.15%, -15.91% and -24.09% apart from the 20-Day, 50-Day and 200-Day Simple Moving Average prices.

As of the close of trading, HCAT deals in the Healthcare domain. The stock is trading -47.60 percent below its 52-week high and 14.09 percent above its 52-week low. For example, looking both at the price and the high and low measurements of 52 weeks will give you a clearer picture of the direction the price is heading. The firm’s Weighted Alpha is -39. A positive weighted alpha indicates the firm has done well over the course of the year, whereas one below 0 indicates that the firm has done poorly.

What Does Health Catalyst Inc’s Profitability and Valuation Ratios Tell Us About the Stock?

With regard to the profitability of the company, the operating margin is currently at -29.21 percent and the profit margin is -39.92 percent, and the company has reported a gross margin of 31.29 percent. The profit margin, also known as the revenue ratio or gross profit ratio, is an efficiency figure used to estimate the business’s profitability by comparing net income and sales. The higher the number, the more profits are generated for the company and vice versa.

The stock’s market cap achieved a total value of $440.96 million as of the last trading session. Market capitalization is the total value of all outstanding shares of a corporation and it is used to measure a company’s market value. The price-to-earnings ratio is a method of assessing corporate values by comparing them to their per-share profit. Forward P/E stands at 14.94. Forward price-to-earnings is calculated using predicted earnings for the next financial year’s P/E determination. The stock has achieved an effective Price-to-Sales Ratio of 1.49 that mirrors the cost to be found for sales by the market. The firm managed a Price-to-Book ratio of 1.20, which equates the market value of a stock with its book value.

Is Insider Trading a Real Thing?

Almost all investors and traders prefer to invest in shares controlled by the management of a corporation as a management company will be more likely to run the business itself and to never conduct things against the management’s desires and will always try to do what is best for their shareholders. Currently, 5.37 percent of Health Catalyst Inc shares are owned by insiders, and 86.80 percent are held by financial institutions. Llewelyn Linda, the Chief People Officer at Health Catalyst Inc (HCAT) has sold 2,005 shares of firm on Mar 15 ’24 at a price of $7.80 against the total amount of $15648.0. In another inside trade, Burton Daniel D., Chief Executive Officer of Health Catalyst Inc (NASDAQ:HCAT) bought 26,200 shares of the firm on Feb 27 ’24 for a total worth of $0.2 million at a price of $7.81. An inside trade which took place on Feb 15 ’24, Chief People Officer of Health Catalyst Inc Llewelyn Linda sold 3,262 shares of firm against total price of $31855.0 at the cost of $9.77 per share.

Most Popular

Related Posts